NanoGVA Symposium

The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal with relevant topics like new characterization methods of advanced materials, manufacturing processes and the regulatory background of nanomedicines.

Related articles

Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Questions about nanomater... New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Country-scale calculation... Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
The need for awareness an... Published in Nature Nanotechnology by the group of Alke Petri-Fink and Barbara Rothen-Rutishauer (www.nature.com/articles/s41565-023-01331-4). The authors discuss the safety concerns on handling and disposing nanomaterials, the possible
Nanomedicine: The Minuten... Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
NanoGVA Symposium The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Clinam Summit in Basel This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October